107 related articles for article (PubMed ID: 10752656)
1. Telomerase, p53 and human papillomavirus infection in the uterine cervix.
Nair P; Jayaprakash PG; Nair MK; Pillai MR
Acta Oncol; 2000; 39(1):65-70. PubMed ID: 10752656
[TBL] [Abstract][Full Text] [Related]
2. Increased angiogenesis in the uterine cervix associated with human papillomavirus infection.
Nair P; Gangadevi T; Jayaprakash PG; Nair MB; Nair MK; Pillai MR
Pathol Res Pract; 1999; 195(3):163-9. PubMed ID: 10220796
[TBL] [Abstract][Full Text] [Related]
3. High-risk human papillomavirus infection and E6 protein expression in lesions of the uterine cervix.
Pillai MR; Lakshmi S; Sreekala S; Devi TG; Jayaprakash PG; Rajalakshmi TN; Devi CG; Nair MK; Nair MB
Pathobiology; 1998; 66(5):240-6. PubMed ID: 9732239
[TBL] [Abstract][Full Text] [Related]
4. Decreased programmed cell death in the uterine cervix associated with high risk human papillomavirus infection.
Nair P; Nair KM; Jayaprakash PG; Pillai MR
Pathol Oncol Res; 1999; 5(2):95-103. PubMed ID: 10393359
[TBL] [Abstract][Full Text] [Related]
5. Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix.
Grace VM; Shalini JV; lekha TT; Devaraj SN; Devaraj H
Gynecol Oncol; 2003 Oct; 91(1):51-8. PubMed ID: 14529662
[TBL] [Abstract][Full Text] [Related]
6. Expression of HPV-16 E6 protein and p53 inactivation increases the uterine cervical cancer invasion.
Yang X; Lu L
Drug Res (Stuttg); 2015 Feb; 65(2):70-3. PubMed ID: 24831244
[TBL] [Abstract][Full Text] [Related]
7. p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions.
Kurvinen K; Syrjänen K; Syrjänen S
J Clin Oncol; 1996 Jul; 14(7):2120-30. PubMed ID: 8683245
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of expression of apoptosis-related proteins and their correlation with HPV, telomerase activity, and apoptotic index in cervical cancer.
Singh A; Sharma H; Salhan S; Gupta SD; Bhatla N; Jain SK; Singh N
Pathobiology; 2004; 71(6):314-22. PubMed ID: 15627842
[TBL] [Abstract][Full Text] [Related]
9. Development of a condemned mucosa syndrome and pathogenesis of human papillomavirus-associated upper aerodigestive tract and uterine cervical tumors.
Pillai MR; Nair MK
Exp Mol Pathol; 2000 Dec; 69(3):233-41. PubMed ID: 11115364
[TBL] [Abstract][Full Text] [Related]
10. Cellular manifestations of human papillomavirus infection in the oral mucosa.
Pillai MR; Phanidhara A; Kesari AL; Nair P; Nair MK
J Surg Oncol; 1999 May; 71(1):10-5. PubMed ID: 10362085
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients.
Cheah PL; Looi LM; Ng MH; Sivanesaratnam V
J Clin Pathol; 2002 Jan; 55(1):22-6. PubMed ID: 11825919
[TBL] [Abstract][Full Text] [Related]
12. Relationship between the expression of telomerase and human papillomavirus infection in invasive uterine cervical carcinoma.
Sima N; Cai L; Zhu Y; Wang W; Wang S; Ma D
J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):451-3. PubMed ID: 17828509
[TBL] [Abstract][Full Text] [Related]
13. The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone.
Ishikawa H; Mitsuhashi N; Sakurai H; Maebayashi K; Niibe H
Cancer; 2001 Jan; 91(1):80-9. PubMed ID: 11148563
[TBL] [Abstract][Full Text] [Related]
14. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the p53 gene and papillomavirus detection in smears from cervical lesions.
dos Santos Oliveira Ldo H; Fernandez Ade P; Xavier BL; Machado Rodrigues Ede V; Cavalcanti SM
Sao Paulo Med J; 2002 Jan; 120(1):20-2. PubMed ID: 11836549
[TBL] [Abstract][Full Text] [Related]
16. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
[TBL] [Abstract][Full Text] [Related]
17. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.
Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G
Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588
[TBL] [Abstract][Full Text] [Related]
18. Relationship between telomerase activation and HPV 16/18 oncogene expression in squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix.
Riethdorf S; Riethdorf L; Schulz G; Ikenberg H; Jänicke F; Löning T; Park TW
Int J Gynecol Pathol; 2001 Apr; 20(2):177-85. PubMed ID: 11293165
[TBL] [Abstract][Full Text] [Related]
19. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
[TBL] [Abstract][Full Text] [Related]
20. A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas.
Koyamatsu Y; Yokoyama M; Nakao Y; Fukuda K; Saito T; Matsukuma K; Iwasaka T
Gynecol Oncol; 2003 Sep; 90(3):547-51. PubMed ID: 13678722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
